科华生物

- 002022

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
科华生物(002022) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入44,330.39242,807.52190,422.25139,647.5883,314.77
营业收入44,330.39242,807.52190,422.25139,647.5883,314.77
二、营业总成本48,238.82253,541.47188,085.78132,945.8573,627.12
营业成本25,689.80139,985.60105,873.0176,278.7444,254.36
营业税金及附加298.721,454.911,009.85719.69383.66
销售费用9,518.5945,847.2534,987.1525,448.7812,849.04
管理费用7,400.3840,849.7226,811.5717,848.338,131.02
财务费用608.151,268.22787.52165.621,427.84
研发费用4,723.1924,135.7918,616.6812,484.696,581.20
资产减值损失----------
公允价值变动收益275.15147.17------
投资收益236.672,293.701,941.631,401.07701.47
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润-2,408.65-17,932.747,919.8510,619.3711,708.61
加:营业外收入9.14155.4540.9124.0728.76
减:营业外支出46.15783.60434.13203.21102.81
其中:非流动资产处置损失----------
四、利润总额-2,445.65-18,560.887,526.6210,440.2311,634.56
减:所得税费用-277.40-862.372,669.672,659.831,917.13
五、净利润-2,168.26-17,698.514,856.967,780.399,717.43
归属于母公司所有者的净利润-2,882.15-23,401.49-1,995.412,112.815,476.19
少数股东损益713.895,702.986,852.375,667.594,241.24
六、每股收益
基本每股收益(元/股)-0.0568-0.4550-0.03880.04110.1065
稀释每股收益(元/股)-0.0568-0.4550-0.03880.04110.1065
七、其他综合收益-905.21509.531,588.922,370.33-229.31
八、综合收益总额-3,073.47-17,188.986,445.8710,150.739,488.12
归属于母公司所有者的综合收益总额-3,614.82-23,333.73-583.524,013.905,282.80
归属于少数股东的综合收益总额541.346,144.757,029.396,136.834,205.32
下载全部历史数据到excel中 返回页顶